These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 35283330

  • 1. Benralizumab Completely Depletes Gastrointestinal Tissue Eosinophils and Improves Symptoms in Eosinophilic Gastrointestinal Disease.
    Kuang FL, De Melo MS, Makiya M, Kumar S, Brown T, Wetzler L, Ware JM, Khoury P, Collins MH, Quezado M, Pittaluga S, Klion AD.
    J Allergy Clin Immunol Pract; 2022 Jun; 10(6):1598-1605.e2. PubMed ID: 35283330
    [Abstract] [Full Text] [Related]

  • 2. Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis.
    Wechsler ME, Klion AD, Paggiaro P, Nair P, Staumont-Salle D, Radwan A, Johnson RR, Kapoor U, Khokhar FA, Daizadeh N, Chen Z, Laws E, Ortiz B, Jacob-Nara JA, Mannent LP, Rowe PJ, Deniz Y.
    J Allergy Clin Immunol Pract; 2022 Oct; 10(10):2695-2709. PubMed ID: 35636689
    [Abstract] [Full Text] [Related]

  • 3. Experimental Modeling of Eosinophil-Associated Diseases.
    Upparahalli Venkateshaiah S, Manohar M, Kandikattu HK, Mishra A.
    Methods Mol Biol; 2021 Oct; 2241():275-291. PubMed ID: 33486743
    [Abstract] [Full Text] [Related]

  • 4. Single-Organ and Multisystem Hypereosinophilic Syndrome Patients with Gastrointestinal Manifestations Share Common Characteristics.
    Kuang FL, Curtin BF, Alao H, Piligian B, Berry A, Holland-Thomas N, Powers A, Quezado M, Lumbard K, Fay MP, Klion AD, Kumar S, Khoury P.
    J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2718-2726.e2. PubMed ID: 32344186
    [Abstract] [Full Text] [Related]

  • 5. Eosinophil infiltration in the upper gastrointestinal tract of patients with bronchial asthma.
    Imaeda H, Yamaoka M, Ohgo H, Yoneno K, Kobayashi T, Noguchi T, Uchida Y, Soma T, Kayano H, Kanazawa M, Nakamoto H, Nagata M.
    Allergol Int; 2016 Sep; 65 Suppl():S6-S10. PubMed ID: 27118436
    [Abstract] [Full Text] [Related]

  • 6. Determination of Biopsy Yield That Optimally Detects Eosinophilic Gastritis and/or Duodenitis in a Randomized Trial of Lirentelimab.
    Dellon ES, Gonsalves N, Rothenberg ME, Hirano I, Chehade M, Peterson KA, Falk GW, Murray JA, Gehman LT, Chang AT, Singh B, Rasmussen HS, Genta RM.
    Clin Gastroenterol Hepatol; 2022 Mar; 20(3):535-545.e15. PubMed ID: 34089846
    [Abstract] [Full Text] [Related]

  • 7. Biologics in eosinophilic gastrointestinal diseases.
    Dellon ES, Spergel JM.
    Ann Allergy Asthma Immunol; 2023 Jan; 130(1):21-27. PubMed ID: 35738437
    [Abstract] [Full Text] [Related]

  • 8. Histologic eosinophilic gastritis is a systemic disorder associated with blood and extragastric eosinophilia, TH2 immunity, and a unique gastric transcriptome.
    Caldwell JM, Collins MH, Stucke EM, Putnam PE, Franciosi JP, Kushner JP, Abonia JP, Rothenberg ME.
    J Allergy Clin Immunol; 2014 Nov; 134(5):1114-24. PubMed ID: 25234644
    [Abstract] [Full Text] [Related]

  • 9. Benralizumab for PDGFRA-Negative Hypereosinophilic Syndrome.
    Kuang FL, Legrand F, Makiya M, Ware J, Wetzler L, Brown T, Magee T, Piligian B, Yoon P, Ellis JH, Sun X, Panch SR, Powers A, Alao H, Kumar S, Quezado M, Yan L, Lee N, Kolbeck R, Newbold P, Goldman M, Fay MP, Khoury P, Maric I, Klion AD.
    N Engl J Med; 2019 Apr 04; 380(14):1336-1346. PubMed ID: 30943337
    [Abstract] [Full Text] [Related]

  • 10. Rebound eosinophilia after treatment of hypereosinophilic syndrome and eosinophilic gastroenteritis with monoclonal anti-IL-5 antibody SCH55700.
    Kim YJ, Prussin C, Martin B, Law MA, Haverty TP, Nutman TB, Klion AD.
    J Allergy Clin Immunol; 2004 Dec 04; 114(6):1449-55. PubMed ID: 15577851
    [Abstract] [Full Text] [Related]

  • 11. Eosinophils in Gastrointestinal Disorders: Eosinophilic Gastrointestinal Diseases, Celiac Disease, Inflammatory Bowel Diseases, and Parasitic Infections.
    Mehta P, Furuta GT.
    Immunol Allergy Clin North Am; 2015 Aug 04; 35(3):413-37. PubMed ID: 26209893
    [Abstract] [Full Text] [Related]

  • 12. Association Between Endoscopic and Histologic Findings in a Multicenter Retrospective Cohort of Patients with Non-esophageal Eosinophilic Gastrointestinal Disorders.
    Pesek RD, Reed CC, Collins MH, Muir AB, Fulkerson PC, Menard-Katcher C, Falk GW, Kuhl J, Magier AZ, Ahmed FN, Demarshall M, Gupta A, Gross J, Ashorobi T, Carpenter CL, Krischer JP, Gonsalves N, Hirano I, Spergel JM, Gupta SK, Furuta GT, Rothenberg ME, Dellon ES, Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR).
    Dig Dis Sci; 2020 Jul 04; 65(7):2024-2035. PubMed ID: 31773359
    [Abstract] [Full Text] [Related]

  • 13. Common and disparate clinical presentations and mechanisms in different eosinophilic gastrointestinal diseases.
    Shoda T, Taylor RJ, Sakai N, Rothenberg ME.
    J Allergy Clin Immunol; 2024 Jun 04; 153(6):1472-1484. PubMed ID: 38555071
    [Abstract] [Full Text] [Related]

  • 14. Role of peripheral and tissue eosinophils and eosinophil cationic protein in pediatric inflammatory bowel disease.
    Kim YI, Yang HR.
    J Pediatr Gastroenterol Nutr; 2024 Mar 04; 78(3):653-661. PubMed ID: 38504407
    [Abstract] [Full Text] [Related]

  • 15. Anti-Siglec-8 Antibody for Eosinophilic Gastritis and Duodenitis.
    Dellon ES, Peterson KA, Murray JA, Falk GW, Gonsalves N, Chehade M, Genta RM, Leung J, Khoury P, Klion AD, Hazan S, Vaezi M, Bledsoe AC, Durrani SR, Wang C, Shaw C, Chang AT, Singh B, Kamboj AP, Rasmussen HS, Rothenberg ME, Hirano I.
    N Engl J Med; 2020 Oct 22; 383(17):1624-1634. PubMed ID: 33085861
    [Abstract] [Full Text] [Related]

  • 16. Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis.
    Rothenberg ME, Dellon ES, Collins MH, Bredenoord AJ, Hirano I, Peterson KA, Brooks L, Caldwell JM, Fjällbrant H, Grindebacke H, Ho CN, Keith M, McCrae C, Sinibaldi D, White WI, Datto CJ, MESSINA Trial Investigators.
    N Engl J Med; 2024 Jun 27; 390(24):2252-2263. PubMed ID: 38924732
    [Abstract] [Full Text] [Related]

  • 17. Developing a standardized approach for assessing mast cells and eosinophils on tissue biopsies: A Work Group Report of the AAAAI Allergic Skin Diseases Committee.
    Zimmermann N, Abonia JP, Dreskin SC, Akin C, Bolton S, Happel CS, Geller M, Larenas-Linnemann D, Nanda A, Peterson K, Wasan A, Wechsler J, Zhang S, Bernstein JA.
    J Allergy Clin Immunol; 2021 Oct 27; 148(4):964-983. PubMed ID: 34384610
    [Abstract] [Full Text] [Related]

  • 18. Dupilumab Can Induce Remission of Eosinophilic Gastritis and Duodenitis: A Retrospective Case Series.
    Sia T, Bacchus L, Tanaka R, Khuda R, Mallik S, Leung J.
    Clin Transl Gastroenterol; 2024 Jan 01; 15(1):e00646. PubMed ID: 37753954
    [Abstract] [Full Text] [Related]

  • 19. Mast Cell and Eosinophil Counts in Gastric and Duodenal Biopsy Specimens From Patients With and Without Eosinophilic Gastroenteritis.
    Reed CC, Genta RM, Youngblood BA, Wechsler JB, Dellon ES.
    Clin Gastroenterol Hepatol; 2021 Oct 01; 19(10):2102-2111. PubMed ID: 32801015
    [Abstract] [Full Text] [Related]

  • 20. Anti-IL-5 therapy reduces mast cell and IL-9 cell numbers in pediatric patients with eosinophilic esophagitis.
    Otani IM, Anilkumar AA, Newbury RO, Bhagat M, Beppu LY, Dohil R, Broide DH, Aceves SS.
    J Allergy Clin Immunol; 2013 Jun 01; 131(6):1576-82. PubMed ID: 23623266
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.